<html>
<head>
  <title>2C19</title>
<style>
  .td {font-family: "verdana"; font-size: "10px"; color: "navy";}
  .green {background-color:"#ACA899";font-family:verdana; font-size:8pt;}
  .lite {background-color:"#F1EFE2";font-family:verdana; font-size:8pt; color:"#666600";}
  A:link {COLOR: "navy"; text-decoration: none;}
  A:visited {COLOR: "navy"; text-decoration: none;}
  A:active {COLOR: "navy"; text-decoration: none;}
  A:hover {COLOR:"#66CCFF";}
  .normal {font-family: "verdana"; font-size: 10; color: "#000000";}
</style>
</head>

<body bgcolor="#FFFFFF" class="normal">
<CENTER>
<TABLE border="0" cellPadding="5" cellSpacing="5" width="90%" class="normal">
<tr><td>
<b>References for Cytochrome P450 Drug Interaction Table: 2C19</b><br><br>
	
These pages contain all the literature citations referenced in the Cytochrome P450 Drug Interaction Tables (both the extensive <a HREF="index.htm">research-oriented table</a> and the concise <a HREF="clinlist.htm"> clinical table</a>). Most of these citations are hyperlinks, which bring up the abstract in the NLM's PubMed database.
	
<p>Click on the [ PubMed ] link after the drug name to perform a live MedLINE search of articles possibly related to that drug and Cytochrome P450.</p>

<p>Entries are organized by mode of activity (substrate, inhibitor, inducer) within specific isoform. You can quickly branch to a section by clicking on the appropriate link here:</p>

<a href="1A2.htm">1A2</a> | <a href="2B6.htm">2B6</a> | <a href="2C8.htm">2C8</a> | 2C19 | <a href="2C19.htm">2C9</a> | <a href="2D6.htm">2D6</a> | <a href="2E1.htm">2E1</a> | <a href="3A457.htm">3A457</a>

<p>Use Ctrl-F to find all or part of the name or word for which you are searching.</p><br>

<hr color="#33CC66">
<hr color="#FF9900">
<p><h3><a name="3A457sub">2C19 SUBSTRATES</a></h3></p>
<hr color="#FF9900">
<hr color="#33CC66">

<p>
<a name="212c19"><b>2C19 Itself:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+CYP2C19&doptcmdl=DocSum">PubMed</a></i>
<p>
<a name="212c19"></a><i>Isolation and Characterization of Human Liver Cytochrome
P450 2C19: correlation between 2C19 and S-mephenytoin
4'-hydroxylation.</i><br>
Wrighton SA, Stevens JC, Becker GW and Vandenbranden M<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=8215410&amp;dopt=Abstract">Pubmed
Biochem Biophys 1993 Oct;306(1):240-245</a>
<p>
<a NAME="21amitriptyline"><b>amitriptyline:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+amitriptyline&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Five distinct human cytochromes mediate amitriptyline N-demethylation
in vitro: dominance of CYP 2C19 and 3A4.</i><br>
Venkatakrishnan K, Greenblatt DJ, von Moltke LL, Schmider J, Harmatz JS,
Shader RI<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9549641&dopt=Abstract">Clin Pharmacol. 1998 Feb; 38(2): 112-121</a>
<p>
<i>Metabolism of the tricyclic antidepressant amitriptyline by cDNA-expressed
human cytochrome P450 enzymes.</i><br>
Olesen OV, Linnet K<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9399333&dopt=Abstract">Pharmacology.
1997 Nov; 55(5): 235-243</a>
<p>
<i>Cytochromes P450 mediating the N-demethylation of amitriptyline.</i><br>
Ghahramani P, Ellis SW, Lennard MS, Ramsay LE, Tucker GT<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9131945&dopt=Abstract">Br
J Clin Pharmacol. 1997 Feb; 43(2): 137-144</a>

<p><a name="S-chloramphenicol"><b>chloramphenicol</b></a>: <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+chloramphenicol+AND+inhibitor&doptcmdl=DocSum"><i>PubMed</i></a></p>
<p><i>Chloramphenicol Is a Potent Inhibitor of Cytochrome P450 Isoforms CYP2C19 and CYP3A4 in Human Liver Microsomes.</i><br>
Park JY, Kim KA, Kim SL.<br>
<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14576103&dopt=Abstract">Antimicrob Agents Chemother. 2003 Nov;47(11):3464-9.</a></p>


<p>
<a name="21citalo"><b>citalopram:</b> </a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+citalopram&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Personal communication with Dr. Terence Ketter about citalopram on March
29, 1995.</i><br>
Ketter, T.A<br>
Flockhart, D.A. 1995
<p>
<a NAME="21clomipramine"><b>clomipramine:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+clomipramine&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Pharmacogenetics of antidepressants: clinical aspects.</i><br>
Bertilsson L, Dahl ML, Tybring G<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9265947&dopt=Abstract">Acta
Psychiatr Scand Suppl 1997;391:14-21</a>
<p>
<a NAME="21cyclophosphamide"><b>cyclophosphamide:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+cyclophosphamide&doptcmdl=DocSum">PubMed</a></i>
<p>
<a NAME="21cyclophosphamide"></a><i>Identification of the polymorphically
expressed CYP2C19 and the wild-type CYP2C9-ILE<sup>359</sup> allele as
low-K<sub>m</sub> catalysts of cyclophosphamide and ifosfamide
activation.</i><br>
Chang TKH, Yu L, Goldstein JA, Waxman DJ<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9241661&dopt=Abstract">Pharmacogenetics
1997;7:211-221</a>

<p>
<a name="21diazep"><b>diazepam:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+diazepam&doptcmdl=DocSum">PubMed</a></i>
<p>
<a name="21diazep"></a><i>Cytochrome P450 mediated metabolism of diazepam
in human and rat: involvement of human CYP2C in N-demethylation in the substrate
concentration-dependent manner.</i><br>
Yasumori T, Nagata K, Yang SK, Chen L-S, Murayama N, Yamazoe Y, Kato R<br>
<a HREF="http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query">Pharmacogenetics
1993;3:291-301</a>

<p>
<a name="21e-3810"><b>E-3810:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+E-3810&doptcmdl=DocSum">PubMed</a></i>
<p>
<a name="21e-3810"></a><i>Comparison of the kinetic disposition and metabolism
of E3810, a new proton pump inhibitor, and omeprazole in relation to
S-mephenytoin 4'-hydroxylation status.</i><br>
Yasuda S, Horai Y, Tomono Y, Nakai H, Yamato C, Manabe K, Kobayashi K, Chiba
K, Ishizaki T<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7648764&dopt=Abstract">Clin
Pharmacol Ther 1995 Aug;58(2):143-154 </a>
</p>

<p><a name="21escitalopram"><b>escitalopram:</b></a>
<i><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+escitalopram&doptcmdl=DocSum">PubMed</a></i>
</p>



<p>
<a NAME="21hexobarbital"><b>hexobarbital:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+hexobarbital&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Stereoselective disposition of hexobarbital and its metabolites: relationship
to the S-mephenytoin polymorphism in Caucasian and Chinese subjects.</i><br>
Adedoyin A, Prakash C, O'Shea D, Blair IA, Wilkinson GR<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8004130&dopt=Abstract">Pharmacogenetics.
1994 Feb; 4(1): 27-38</a>
<p>
<i>Polymorphism in stereoselective hydroxylations of mephenytoin and hexobarbital
by Japanese liver samples in relation to cytochrome P-450 human-2
(IIC9).</i><br>
Kato R, Yamazoe Y, Yasumori T<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1441599&dopt=Abstract">Xenobiotica.
1992 Sep; 22(9-10): 1083-1092. Review</a>
<p>
<i>Polymorphism in hydroxylation of mephenytoin and hexobarbital stereoisomers
in relation to hepatic P-450 human-2.</i><br>
Yasumori T, Murayama N, Yamazoe Y, Kato R<i><br>
</i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2311333&dopt=Abstract">Clin
Pharmacol Ther. 1990 Mar; 47(3): 313-322</a>
<p>
<i>Oxidative metabolism of hexobarbital in human liver: relationship to
polymorphic S-mephenytoin 4-hydroxylation.</i><br>
Knodell RG, Dubey RK, Wilkinson GR, Guengerich FP<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=3385644&dopt=Abstract">J
Pharmacol Exp Ther. 1988 Jun; 245(3): 845-849</a>
<p>
<a NAME="21imipramine"><b>imipramine N-deME: </b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+imipramine&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Reappraisal of human CYP isoforms involved in imipramine N-demethylation
and 2-hydroxylation: a study using microsomes obtained from putative extensive
and poor metabolizers of S-mephenytoin and eleven recombinant human
CYPs.</i><br>
Koyama E, Chiba K, Tani M, Ishizaki T<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9190854&dopt=Abstract">J
Pharmacol Exp Ther. 1997 Jun; 281(3): 1199-1210.</a>
<p>
<i>Geographical/interracial differences in polymorphic drug oxidation. Current
state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19.</i><br>
Bertilsson L.<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8521680&dopt=Abstract">Clin
Pharmacokinet. 1995 Sep; 29(3): 192-209. Review.</a>
<p>
<a name="21indome"><b>indomethacin:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+indomethacin&doptcmdl=DocSum">PubMed</a></i>
<p>
<a name="21indome"></a><i>Human cytochrome P4502C metabolism.</i><br>
Weaver RJ, Webster D, Melvin WT, Dickins M and Burke MD<br>
Br J Clin Pharmacol 1993 April;36(2):167P
<p>
<a NAME="21lansoprazole"><b>lansoprazole:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+lansoprazole&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Metabolic disposition of lansoprazole in relation to the S-mephenytoin
4'-hydroxylation phenotype status.</i><br>
Sohn DR, Kwon JT, Kim HK, Ishizaki T<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9164419&dopt=Abstract">Clin
Pharmacol Ther 1997 May;61(5):574-582</a>
<p>
<a NAME="21Smephenytoin"><b>S-mephenytoin:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+s-mephenytoin&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Mephenytoin hydroxylation deficiency in Caucasians: frequency of a new
oxidative drug metabolism polymorphism.</i><br>
Wedlund PJ, Aslanian WS, McAllister CB, Wilkinson GR, Branch RA<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6499356&dopt=Abstract">Clin
Pharmacol Ther, 1984 Dec; 36(6):773-780</a>
<p>
<a NAME="21Rmephobarbital"><b>R-mephobarbital:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+R-mephobarbital&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Stereoselective mephobarbital hydroxylation cosegregates with mephenytoin
hydroxylation.</i><br>
Kupfer A, Branch RA<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=4042524&dopt=Abstract">Clin
Pharmacol Ther, 1985 Oct; 38(4):414-418</a>
<p>
<a name="21moclob"><b>moclobemide:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+moclobemide&doptcmdl=DocSum">PubMed</a></i>
<p>
<a name="21moclob"></a><i>Moclobemide: a substrate of CYP2C19 and an inhibitor
of CYP2C19, CYP2D6 and CYP1A2: A panel study.</i><br>
Gram LF, Guentert TW, Grange S, Vistisen K, Brøsen K<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7781267&dopt=Abstract">Clin
Pharmacol Ther 1995;57(6):670-677</a>
<p>
<a NAME="21nelfinavir"><b>nelfinavir:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+nelfinavir&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Characterization of the selectivity and mechanism of human cytochrome
P450 inhibition by the human immunodeficiency virus-protease inhibitor nelfinavir
mesylate.</i><br>
Lillibridge JH, Liang BH, Kerr BM, Webber S, Quart B, Shetty BV, Lee CA<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9660842&dopt=Abstract">Drug
Metab Dispos 1998 Jul;26(7):609-16 </a>
<p>
<a NAME="21nilutamide"><b>nilutamide: </b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+nilutamide&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Nilutamide inhibits mephenytoin 4-hydroxylation in untreated male rats
and in human liver microsomes.</i><br>
Horsmans Y, Lannes D, Larrey D, Tinel M, Letteron P, Loeper J, Pessayre D<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1785203&dopt=Abstract">Xenobiotica
1991 Dec;21(12):1559-1570</a>
<p>
<a name="21omepra"><b>omeprazole:</b> </a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+omeprazole&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Effect of omeprazole on diazepam plasma levels in slow versus normal rapid
metabolizers of omeprazole.</i><br>
Andersson T, Cederberg C, Edvardsson G, Heggelund A, Lundborg P<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2104790&dopt=Abstract">Clin
Pharmacol Ther 1990;47(1):79-85</a>

<p><a name="S-oxcarbazepine"><b>Oxcarbazepine:</b></a>
<i><a href="">PubMed</a></i><br><br>
<i>Spotlight on oxcarbazepine in epilepsy.</i><br>
Bang LM, Goa KL.<br>
<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14731060">CNS Drugs. 2004;18(1):57-61.</a>
</p>
<p>
<a NAME="21pantoprazole"><b>pantoprazole:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+pantoprazole&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Metabolic disposition of pantoprazole, a proton pump inhibitor, in relation
to S-mephenytoin 4'-hydroxylation phenotype and genotype.</i><br>
Tanaka M, Ohkubo T, Otani K, Suzuki A, Kaneko S, Sugawara K, Ryokawa Y, Hakusui
H, Yamamori S, Ishizaki T<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9433390&dopt=Abstract">Clin
Pharmacol Ther 1997 Dec;62(6):619-628</a>
<p>
<a name="21phenyt"><b>phenytoin:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+phenytoin&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Role of S-mephenytoin hydroxylase in the metabolism of phenytoin.</i><br>
Bajpai M, Roskos LK, Shen DD, Trager WF, Levy RH<br>
Pharm Res 1994, 11(Suppl):S348
<p>
<b><a NAME="21phenobarb">phenobarbitone:</a></b><font COLOR="#ff00ff"><b><a NAME="21phenobarb">
</a></b></font><font COLOR="Blue"><i><u><a HREF="http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?CMD=Search&amp;DB=PubMed">Pubmed</a></u></i></font>
<p>
<i>CYP2C19 polymorphism effect on phenobarbitone. Pharmacokinetics in Japanese
patients with epilepsy: analysis by population pharmacokinetics.</i><br>
Mamiya K, Hadama A, Yukawa E, Ieiri I, Otsubo K, Ninomiya H, Tashiro N, Higuchi
S<br>
Eur J Clin Pharmacol 2000, 55:821-825
<p>
<b><a NAME="21primidone">primidone:</a></b>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+primidone&doptcmdl=DocSum">PubMed</a></i>
<p>
<a NAME="21progesterone"><b>progesterone:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+progesterone&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Progesterone and testosterone hydroxylation by CYP 2C19, 2C9 and 3A4 in
human liver microsomes.</i><br>
Yamazaki H, Shimada T<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9328296&dopt=Abstract">Arch
Biochem Biophys 1997;346(1):161-169</a>
<p>
<a name="21progua"><b>proguanil:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+proguanil&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Metabolic Disposition of proguanil in extensive and poor metabolizers
of S-mephenytoin 4'-hydroxylation recruited from an Indonesian
population.</i><br>
Setiabudy R, Kusaka M, Chiba K, Darmansjah I, Ishizaki T<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7619672&dopt=Abstract">Br
J Clin Pharmacol 1995;39(3):297-303</a>
<p>
<i>In vitro proguanil activation to cycloguanil by human liver microsomes
is mediated by CYP3A isoforms as well as S-mephenytoin hydroxylase.</i><br>
Birkett DJ, Rees D, Andersson T, Gonzalex FJ, Miners JO, Veronese ME<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8054246&dopt=Abstract">Br
J Clin Pharmacol 1994;37:413-420</a>
<p>
<i>The activation of the biguanide anti-malarial proguanil co-segregates
with the mephenytoin oxidation polymorphism - a panel study.</i><br>
Ward SA, Helsby NA, Skjelbo E, Brøsen K, Gram LF, Breckenridge AM<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1867963&dopt=Abstract">Br
J Clin Pharmacol 1991;31:689-692</a>
<p>
<i>Relation between chloroguanide bioavtivation to cycloguanil and the
genetically determined metabolism of mephenytoin in humans.</i><br>
Funck-Brentano C, Bosco O, Jacqz-Aigrain E, KeunjiN a, Jaillon P<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1587064&dopt=Abstract">Clin
Pharmacol Ther 1992;51(5):507-512</a>
<p>
<a name="21propra"><b>propranolol:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+propranolol&doptcmdl=DocSum">PubMed</a></i>
<p>
<a name="21propra"></a><b>Not in vitro.</b> <i>Propranolol oxidation by human liver microsomes-- use of cumene hydroperoxide to probe isoenzyme specificity and regio- and stereoselectivity.</i><br>
Otton SV, Gillam EM, Lennard MS, Tucker GT, Woods HF<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2271375&dopt=Abstract">Br J Clin Pharmacol 1990 Nov;30(5):751-760</a>

<p><a name="21rabeprazole"><b>rabeprazole: </b></a><i>Acid-suppressive effects of rabeprazole, omeprazole, and lansoprazole at reduced and standard doses: a crossover comparative study in homozygous extensive metabolizers of cytochrome P450 2C19.</i><br>
Shimatani T, Inoue M, Kuroiwa T, Xu J, Mieno H, Nakamura M, Tazuma S.<br>
<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16413249&query_hl=3&itool=pubmed_docsum">Clin Pharmacol Ther. 2006 Jan;79(1):144-52.</a><br>
</p>




<p>
<a name="21r-warf"><b>R-warfarin:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+R-warfarin&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Correlation of human cytochrome P450 2C substrate specificities with primary
structure: warfarin as a probe.</i><br>
Kaminsky LS, de Morais SM, Faletto MB, Dunbar DA, Goldstein JA<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8429826&dopt=Abstract">Mol
Pharmacol 1993;43:234-239</a>
<p>
<b><a NAME="21teniposide">teniposide:</a></b>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+teniposide&doptcmdl=DocSum">PubMed</a></i>


<hr color="#33CC66">
<hr color="#FF9900">
<p><h3><a name="3A457sub">2C19 INHIBITORS</a></h3></p>
<hr color="#FF9900">
<hr color="#33CC66">

<table class="normal">
<tr class="normal"><td width="125"><a name="cimetidine"><b>CIMETIDINE</b></a></td>
<td>[ <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+cimetidine+AND+substrate&doptcmdl=DocSum">PubMed</a> ]</td></tr>
<tr class="normal" valign="top"><td>Article</td><td>Inhibition of drug metabolism in human liver microsomes by nizatidine, cimetidine and omeprazole.</td></tr>
<tr class="normal"><td>Authors</td><td>Furuta S, Kamada E, Suzuki T, Sugimoto T, Kawabata Y, Shinozaki Y, Sano H.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11334262&dopt=Abstract">Xenobiotica. 2001 Jan;31(1):1-10.</a><br><br></td></tr>
<tr class="normal"><td>Info</td><td><a href="http://www.rxlist.com/cgi/generic/cimet.htm">www.rxlist.com</a></td></tr>
</table>

<hr color="#33CC66">
<table class="normal">
<tr class="normal"><td width="125"><a name="chloramphenicol"><b>CHLORAMPHENICOL</b></a></td>
<td>[ <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+chloramphenicol+AND+substrate&doptcmdl=DocSum">PubMed</a> ]</td></tr>
<tr class="normal" valign="top"><td>Article</td><td>Chloramphenicol Is a Potent Inhibitor of Cytochrome P450 Isoforms CYP2C19 and CYP3A4 in Human Liver Microsomes.</td></tr>
<tr class="normal"><td>Authors</td><td>Park JY, Kim KA, Kim SL.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14576103&dopt=Abstract">Antimicrob Agents Chemother. 2003 Nov;47(11):3464-9.</a><br><br></td></tr>
<tr class="normal"><td>Info</td><td><a href="http://www.rxlist.com/cgi/generic/chloramphenicol.htm">www.rxlist.com</a></td></tr>

</table>

<hr color="#33CC66">
<table class="normal">
<tr class="normal"><td width="125"><a name="E3810"><b>E3810</b></a></td>
<td>[ <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+pantoprazole+AND+substrate&doptcmdl=DocSum">PubMed</a> ]</td></tr>
<tr class="normal" valign="top"><td>Article</td><td>Comparison of the kinetic disposition and metabolism of E3810, a new proton pump inhibitor, and omeprazole in relation to S-mephenytoin 4'-hydroxylation status.</td></tr>
<tr class="normal"><td>Authors</td><td>Yasuda S, Horai Y, Tomono Y, Nakai H, Yamato C, Manabe K, Kobayashi K, Chiba K, Ishizaki T.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7648764&dopt=Abstract">Clin Pharmacol Ther 1995 Aug;58(2):143-154.</a><br><br></td></tr>

<tr class="normal" valign="top"><td>Article</td><td>Comparison of the interaction potential of a new proton pump inhibitor, E3810, versus omeprazole with diazepam in extensive and poor metabolizers of S-mephenytoin 4'-hydroxylation.</td></tr>
<tr class="normal"><td>Authors</td><td>Ishizaki T, Chiba K, Manabe K, Koyama E, Hayashi M, Yasuda S, Horai Y, Tomono Y, Yamato C, Toyoki T.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7648765&dopt=Abstract">Clin Pharmacol Ther. 1995 Aug;58(2):155-64.</a></td></tr>


</table>
<hr color="#33CC66">

<table class="normal">
<tr class="normal"><td width="125"><a name="felbamate"><b>FELBAMATE</b></a></td>
<td>[ <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+felbamate+AND+substrate&doptcmdl=DocSum">PubMed</a> ]</td></tr>
<tr class="normal" valign="top"><td>Article</td><td></td></tr>
<tr class="normal"><td>Authors</td><td></td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14576103&dopt=Abstract"></a><br><br></td></tr>
<tr class="normal"><td>Info</td><td><a href="http://www.rxlist.com/cgi/generic/chloramphenicol.htm">www.rxlist.com</a></td></tr>
</table>
<hr color="#33CC66">

<table class="normal">
<tr class="normal"><td width="125"><a name="fluoxetine"><b>FLUOXETINE</b></a></td>
<td>[ <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+fluoxetine+AND+substrate&doptcmdl=DocSum">PubMed</a> ]</td></tr>
<tr class="normal" valign="top"><td>Article</td><td>Evaluation of time-dependent cytochrome P450 inhibition using cultured human hepatocytes.</td></tr>
<tr class="normal"><td>Authors</td><td>McGinnity DF, Berry AJ, Kenny JR, Grime K, Riley RJ.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16679385&dopt=Abstract">Drug Metab Dispos. 2006 Aug;34(8):1291-300.</a><br><br></td></tr>

<tr class="normal" valign="top"><td>Article</td><td>Fluoxetine pharmacokinetics and effect on CYP2C19 in young and elderly volunteers.</td></tr>
<tr class="normal"><td>Authors</td><td>Harvey AT, Preskorn SH.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11270912&dopt=Abstract">J Clin Psychopharmacol. 2001 Apr;21(2):161-6.</a><br><br></td></tr>

<tr class="normal" valign="top"><td>Article</td><td>Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine.</td></tr>
<tr class="normal"><td>Authors</td><td>Jeppesen U, Gram LF, Vistisen K, Loft S, Poulsen HE, Brøsen K.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8880055&dopt=Abstract">Eur J Clin Pharmacol. 1996;51(1):73-8.</a><br><br></td></tr>

<tr class="normal" valign="top"><td>Article</td><td>The effects of selective serotonin reuptake inhibitors and their metabolites on S-mephenytoin 4'-hydroxylase activity in human liver microsomes.</td></tr>
<tr class="normal"><td>Authors</td><td>Kobayashi K, Yamamoto T, Chiba K, Tani M, Ishizaki T, Kuroiwa Y.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8703653&dopt=Abstract">Br J Clin Pharmacol. 1995 Nov;40(5):481-5.</a><br><br></td></tr>

<tr class="normal"><td>Info</td><td><a href="http://www.rxlist.com/cgi/generic/fluoxetine.htm">www.rxlist.com</a></td></tr>
</table>
<hr color="#33CC66">

<table class="normal">
<tr class="normal"><td width="125"><a name="fluvoxamine"><b>FLUVOXAMINE</b></a></td>
<td>[ <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+fluoxetine+AND+substrate&doptcmdl=DocSum">PubMed</a> ]</td></tr>
<tr class="normal" valign="top"><td>Article</td><td>Effect of fluvoxamine on the pharmacokinetics of roflumilast and roflumilast N-oxide.</td></tr>
<tr class="normal"><td>Authors</td><td>von Richter O, Lahu G, Huennemeyer A, Herzog R, Zech K, Hermann R.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17596106&dopt=Abstract">Clin Pharmacokinet. 2007;46(7):613-22.</a><br><br></td></tr>

<tr class="normal" valign="top"><td>Article</td><td>Different inhibitory effect of fluvoxamine on omeprazole metabolism between CYP2C19 genotypes.</td></tr>
<tr class="normal"><td>Authors</td><td>Yasui-Furukori N, Takahata T, Nakagami T, Yoshiya G, Inoue Y, Kaneko S, Tateishi T.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15025747&dopt=Abstract">Br J Clin Pharmacol. 2004 Apr;57(4):487-94.</a><br><br></td></tr>

<tr class="normal" valign="top"><td>Article</td><td>Effects of concomitant fluvoxamine on the metabolism of alprazolam in Japanese psychiatric patients: interaction with CYP2C19 mutated alleles.</td></tr>
<tr class="normal"><td>Authors</td><td>Suzuki Y, Shioiri T, Muratake T, Kawashima Y, Sato S, Hagiwara M, Inoue Y, Shimoda K, Someya T.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12698310&dopt=Abstract">Eur J Clin Pharmacol. 2003 Apr;58(12):829-33.</a><br><br></td></tr>


<tr class="normal"><td>Info</td><td><a href="http://www.rxlist.com/cgi/generic/fluvox.htm">www.rxlist.com</a></td></tr>
</table>
<hr color="#33CC66">


<table class="normal">
<tr class="normal"><td width="125"><a name="indomethacin"><b>INDOMETHACIN</b></a></td>
<td>[ <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+indomethacin+AND+substrate&doptcmdl=DocSum">PubMed</a> ]</td></tr>
<tr class="normal" valign="top"><td>Article</td><td>Cytochrome P450 2C9 catalyzes indomethacin O-demethylation in human liver microsomes.</td></tr>
<tr class="normal"><td>Authors</td><td>Nakajima M, Inoue T, Shimada N, Tokudome S, Yamamoto T, Kuroiwa Y.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9492390&dopt=Abstract">Drug Metab Dispos. 1998 Mar;26(3):261-6.</a><br><br></td></tr>

<tr class="normal"><td>Info</td><td><a href="http://www.rxlist.com/cgi/generic/fluvox.htm">www.rxlist.com</a></td></tr>
</table>
<hr color="#33CC66">

<table class="normal">
<tr class="normal"><td width="125"><a name="ketoconazole"><b>KETOCONAZOLE</b></a></td>
<td>[ <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+ketoconazole+AND+substrate&doptcmdl=DocSum">PubMed</a> ]</td></tr>
<tr class="normal" valign="top"><td>Article</td><td>Highly selective inhibition of human CYP3Aa in vitro by azamulin and evidence that inhibition is irreversible.</td></tr>
<tr class="normal"><td>Authors</td><td>Stresser DM, Broudy MI, Ho T, Cargill CE, Blanchard AP, Sharma R, Dandeneau AA, Goodwin JJ, Turner SD, Erve JC, Patten CJ, Dehal SS, Crespi CL.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14709627&dopt=Abstract">Drug Metab Dispos. 2004 Jan;32(1):105-12.</a><br><br></td></tr>

<tr class="normal" valign="top"><td>Article</td><td>In vitro inhibitory effect of 1-aminobenzotriazole on drug oxidations catalyzed by human cytochrome P450 enzymes: a comparison with SKF-525A and ketoconazole.</td></tr>
<tr class="normal"><td>Authors</td><td>Emoto C, Murase S, Sawada Y, Jones BC, Iwasaki K.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15618748&dopt=Abstract">Drug Metab Pharmacokinet. 2003;18(5):287-95.</a><br><br></td></tr>


<tr class="normal"><td>Info</td><td><a href="http://www.rxlist.com/cgi/generic/ketocon.htm">www.rxlist.com</a></td></tr>
</table>


<hr color="#33CC66">
<table class="normal">
<tr class="normal"><td width="125"><a name="lansoprazole"><b>&raquo;&nbsp;LANSOPRAZOLE</b></a></td>
<td>[ <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+lansoprazole+AND+substrate&doptcmdl=DocSum">PubMed</a> ]</td></tr>
<tr class="normal"><td>Article</td><td>Evaluation of omeprazole and lansoprazole as inhibitors of cytochrome P450 isoforms.</td></tr>
<tr class="normal"><td>Authors</td><td>Ko JW, Sukhova N, Thacker D, Chen P, Flockhart DA.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9224780&dopt=Abstract">Eur J Clin Pharmacol 1985;28:257-261.</a><br><br></td></tr>

<tr class="normal" valign="top"><td>Article</td><td>Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.</td></tr>
<tr class="normal"><td>Authors</td><td>Li XQ, Andersson TB, Ahlström M, Weidolf L.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15258107&dopt=Abstract">Drug Metab Dispos. 2004 Aug;32(8):821-7.</a><br><br></td></tr>

<tr class="normal" valign="top"><td>Article</td><td>Stereoselective inhibition of cytochrome P450 forms by lansoprazole and omeprazole in vitro.</td></tr>
<tr class="normal"><td>Authors</td><td>Liu KH, Kim MJ, Shon JH, Moon YS, Seol SY, Kang W, Cha IJ, Shin JG.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15788366&dopt=Abstract">Xenobiotica. 2005 Jan;35(1):27-38.</a><br><br></td></tr>

<tr class="normal"><td>Info</td><td><a href="http://www.rxlist.com/cgi/generic/lansop.htm">www.rxlist.com</a></td></tr>
</table>
<hr color="#33CC66">

<table class="normal">
<tr class="normal"><td width="125"><a name="modafinil"><b>MODAFINIL</b></a></td>
<td>[ <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+modafinil+AND+substrate&doptcmdl=DocSum">PubMed</a> ]</td></tr>
<tr class="normal" valign="top"><td>Article</td><td>In vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil.</td></tr>
<tr class="normal"><td>Authors</td><td>Robertson P, DeCory HH, Madan A, Parkinson A.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10820139&dopt=Abstract">Drug Metab Dispos. 2000 Jun;28(6):664-71.</a><br><br></td></tr>

<tr class="normal"><td>Info</td><td><a href="http://www.rxlist.com/cgi/generic/ketocon.htm">www.rxlist.com</a></td></tr>
</table>

<hr color="#33CC66">
<table class="normal">
<tr class="normal"><td width="125"><a name="omeprazole"><b>&raquo;&nbsp;OMEPRAZOLE</b></a></td>
<td>[ <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+omeprazole+AND+substrate&doptcmdl=DocSum">PubMed</a> ]</td></tr>
<tr class="normal"><td>Article</td><td>Evaluation of omeprazole and lansoprazole as inhibitors of cytochrome P450 isoforms.</td></tr>
<tr class="normal"><td>Authors</td><td>Ko JW, Sukhova N, Thacker D, Chen P, Flockhart DA.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9224780&dopt=Abstract">Eur J Clin Pharmacol 1985;28:257-261.</a><br><br></td></tr>

<tr class="normal"><td>Info</td><td><a href="http://www.rxlist.com/cgi/generic/lansop.htm">www.rxlist.com</a></td></tr>
</table>

<hr color="#33CC66">
<table class="normal">
<tr class="normal"><td width="125"><a name="oxcarbazepine"><b>&raquo;&nbsp;OXCARBAZEPINE</b></a></td>
<td>[ <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+oxcarbazepine+AND+substrate&doptcmdl=DocSum">PubMed</a> ]</td></tr>
<tr class="normal"><td>Article</td><td>Spotlight on oxcarbazepine in epilepsy.</td></tr>
<tr class="normal"><td>Authors</td><td>Bang LM, Goa KL.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14731060&dopt=Abstract">CNS Drugs. 2004;18(1):57-61.</a><br><br></td></tr>

<tr class="normal"><td>Article</td><td>Carbamazepine and oxcarbazepine decrease phenytoin metabolism through inhibition of CYP2C19.</td></tr>
<tr class="normal"><td>Authors</td><td>Lakehal F, Wurden CJ, Kalhorn TF, Levy RH.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12458024&dopt=Abstract">Epilepsy Res. 2002 Dec;52(2):79-83.</a><br><br></td></tr>

<tr class="normal"><td>Info</td><td><a href="http://www.rxlist.com/cgi/generic/lansop.htm">www.rxlist.com</a></td></tr>
</table>
<hr color="#33CC66">

<table class="normal">
<tr class="normal"><td width="125"><a name="pantoprazole"><b>&raquo;&nbsp;PANTOPRAZOLE</b></a></td>
<td>[ <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+pantoprazole+AND+substrate&doptcmdl=DocSum">PubMed</a> ]</td></tr>
<tr class="normal"><td>Article</td><td>Metabolic disposition of pantoprazole, a proton pump inhibitor, in relation to S-mephenytoin 4'-hydroxylation phenotype and genotype.</td></tr>
<tr class="normal"><td>Authors</td><td>Tanaka M, Ohkubo T, Otani K, Suzuki A, Kaneko S, Sugawara K, Ryokawa Y, Hakusui H, Yamamori S, Ishizaki T.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9433390&dopt=Abstract">Clin Pharmacol Ther 1997 Dec;62(6):619-628.</a><br><br></td></tr>
<tr class="normal"><td>Info</td><td><a href="http://www.rxlist.com/cgi/generic/protonix.htm">www.rxlist.com</a></td></tr>
</table>
<hr color="#33CC66">


<table class="normal">
<tr class="normal"><td width="125"><a name="probenicid"><b>&raquo;&nbsp;PROBENICID</b></a></td>
<td>[ <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+probenicid+AND+substrate&doptcmdl=DocSum">PubMed</a> ]</td></tr>
<tr class="normal"><td>Article</td><td></td></tr>
<tr class="normal"><td>Authors</td><td></td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9433390&dopt=Abstract"></a><br><br></td></tr>
<tr class="normal"><td>Info</td><td><a href="http://www.rxlist.com/cgi/generic/protonix.htm">www.rxlist.com</a></td></tr>
</table>

<hr color="#33CC66">
<table class="normal">
<tr class="normal"><td width="125"><a name="rabeprazole"><b>&raquo;&nbsp;RABEPRAZOLE</b></a></td>
<td>[ <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+pantoprazole+AND+rabeprazole&doptcmdl=DocSum">PubMed</a> ]</td></tr>
<tr class="normal" valign="top"><td>Article</td><td>Acid-suppressive effects of rabeprazole, omeprazole, and lansoprazole at reduced and standard doses: a crossover comparative study in homozygous extensive metabolizers of cytochrome P450 2C19.</td></tr>
<tr class="normal"><td>Authors</td><td>Shimatani T, Inoue M, Kuroiwa T, Xu J, Mieno H, Nakamura M, Tazuma S.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16413249&dopt=Abstract">Clin Pharmacol Ther. 2006 Jan;79(1):144-52.</a><br><br></td></tr>

<tr class="normal" valign="top"><td>Article</td><td>Different effects of fluvoxamine on rabeprazole pharmacokinetics in relation to CYP2C19 genotype status.</td></tr>
<tr class="normal"><td>Authors</td><td>Uno T, Shimizu M, Yasui-Furukori N, Sugawara K, Tateishi T.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16487224&dopt=Abstract">Br J Clin Pharmacol. 2006 Mar;61(3):309-14.</a><br><br></td></tr>
<tr class="normal"><td>Info</td><td><a href="http://www.rxlist.com/cgi/generic/aciphex.htm">www.rxlist.com</a></td></tr>

<tr class="normal"><td>Info</td><td><a href="http://www.rxlist.com/cgi/generic/aciphex.htm">www.rxlist.com</a></td></tr>
</table>
<hr color="#33CC66">

<table class="normal">
<tr class="normal"><td width="125"><a name="ticlopidine"><b>&raquo;&nbsp;TICLOPIDINE</b></a></td>
<td>[ <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+ticlopidine+AND+substrate&doptcmdl=DocSum">PubMed</a> ]</td></tr>
<tr class="normal"><td>Article</td><td>Interaction magnitude, pharmacokinetics and pharmacodynamics of ticlopidine in relation to CYP2C19 genotypic status.</td></tr>
<tr class="normal"><td>Authors</td><td>Ieiri I, Kimura M, Irie S, Urae A, Otsubo K, Ishizaki T.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16272957&dopt=Abstract">Pharmacogenet Genomics. 2005 Dec;15(12):851-9.</a><br><br></td></tr>

<tr class="normal"><td>Article</td><td>Ticlopidine decreases the in vivo activity of CYP2C19 as measured by omeprazole metabolism.</td></tr>
<tr class="normal"><td>Authors</td><td>Tateishi T, Kumai T, Watanabe M, Nakura H, Tanaka M, Kobayashi S.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10233213&dopt=Abstract">Br J Clin Pharmacol. 1999 Apr;47(4):454-7.</a><br><br></td></tr>

<tr class="normal"><td>Article</td><td>Ticlopidine as a selective mechanism-based inhibitor of human cytochrome P450 2C19.</td></tr>
<tr class="normal"><td>Authors</td><td>Ha-Duong NT, Dijols S, Macherey AC, Goldstein JA, Dansette PM, Mansuy D.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11580286&dopt=Abstract">Biochemistry. 2001 Oct 9;40(40):12112-22.</a><br><br></td></tr>

<tr class="normal"><td>Article</td><td>Ticlopidine inhibition of phenytoin metabolism mediated by potent inhibition of CYP2C19.</td></tr>
<tr class="normal"><td>Authors</td><td>Donahue SR, Flockhart DA, Abernethy DR, Ko JW.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9390115&dopt=Abstract">Clin Pharmacol Ther. 1997 Nov;62(5):572-7.</a><br><br></td></tr>

<tr class="normal"><td>Info</td><td><a href="http://www.rxlist.com/cgi/generic/protonix.htm">www.rxlist.com</a></td></tr>
</table>
<hr color="#33CC66">

<table class="normal">
<tr class="normal"><td width="125"><a name="topiramate"><b>&raquo;&nbsp;TOPIRAMATE</b></a></td>
<td>[ <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+topiramate+AND+substrate&doptcmdl=DocSum">PubMed</a> ]</td></tr>
<tr class="normal"><td>Article</td><td>Topiramate and phenytoin pharmacokinetics during repetitive monotherapy and combination therapy to epileptic patients.</td></tr>
<tr class="normal" valign="top"><td>Authors</td><td>Sachdeo RC, Sachdeo SK, Levy RH, Streeter AJ, Bishop FE, Kunze KL, Mather GG, Roskos LK, Shen DD, Thummel KE, Trager WF, Curtin CR, Doose DR, Gisclon LG, Bialer M.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12102670&dopt=Abstract">Epilepsia. 2002 Jul;43(7):691-6.</a><br><br></td></tr>
<tr class="normal"><td>Info</td><td><a href="http://www.rxlist.com/cgi/generic/protonix.htm">www.rxlist.com</a></td></tr>
</table>

<hr color="#33CC66">
<hr color="#FF9900">
<p><h3><a name="3A457sub">2C19 INDUCERS</a></h3></p>
<hr color="#FF9900">
<hr color="#33CC66">


<p>
<b><a NAME="23carbamazepine">carbamazepine:</a></b>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+carbamazepine&doptcmdl=DocSum">PubMed</a></i>
<p>
<b><a NAME="23norethindrone">norethindrone:</a></b>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+norethindrone&doptcmdl=DocSum">PubMed</a></i>
<p>
<a name="23notpent"><b>NOT pentobarbital:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+pentobarbital&doptcmdl=DocSum">PubMed</a></i>
<p>
<a name="23notpent"></a><i>Influence of enzyme induction and inhibition on
the oxidation of nifedipine, mephenytoin and antipyrine in humans as assessed
by a &quot;cocktail&quot; study design.</i><br>
Schellens JHM, van der Wart JHF, Brugman M, Breimer DD<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2724144&dopt=Abstract">J
Pharmac Exp Ther 1989;249(2):638-645</a>
<p>
<a name="23predni"><b>prednisone:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+prednisone&doptcmdl=DocSum">PubMed</a></i>
<p>
<a name="23predni"></a><i>Influence of corticosteroid on hexobarbital and
tolbutamide disposition</i>.<br>
Breimer DD, Zilly W, Richter E<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=679598&dopt=Abstract">Clin
Pharmacol Ther 1978 Aug;24(2):208-212</a>
<p>
<a name="23rifamp"><b>rifampin:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+rifampin&doptcmdl=DocSum">PubMed</a></i>
<p>
<a name="23rifamp"></a><i>Induction of polymorphic 4'-hydroxylation of
S-mephenytoin by rifampicin.</i><br>
Zhou HH, Anthony LB, Wood AJJ, Wilkinson GR<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2223426&dopt=Abstract">Br
J Clin Pharmacol 1990;30:471-475</a>
</body></html>
